Healthcare Beyond Barriers

Digipharm brings together industry expertise, a mature concept and revolutionary blockchain technology to facilitate the transformation of healthcare to a value-based approach. 

Spiralling healthcare costs combined with resource constraints have resulted in an unremitting burden on health systems. Trade-offs need to be made, patients are at risk of being denied innovative treatments and there remains barriers to reimbursement for manufacturers. 

Digipharm bypasses infrastructural limitations to enable the implementation of flexible value-based pricing agreements using smart contracts, the development of unprecedented evidence platforms and the ability to reward patients for contributing their data.


This Whitepaper is provided by Digipharm GmbH for informational purposes only. Nothing in this Whitepaper shall be construed as an offer to sell or buy securities in any jurisdiction, or a solicitation for investment, or an investment advice. The Whitepaper does not regulate any sale and purchase of DPH tokens (as referred to in the Whitepaper). The purchase of DPH tokens is subject to the Token Sale Terms and Conditions and the use of DPH is subject to the Platform Terms and Policies. 
This Whitepaper describes the current vision for the DPH platforms. While we intend to attempt to realize this vision, please recognize that it is dependent on quite a number of factors and subject to quite a number of risks. It is entirely possible that platforms will never be implemented or adopted, or that only a portion of our vision will be realized. We do not guarantee or warrant any of the statements in this Whitepaper, because they are based on our current beliefs, expectations and assumptions, about which there can be no assurance due to various anticipated and unanticipated events that may occur. Blockchain, cryptocurrencies and other aspects of the technology used for the DPH platforms is in its infancy and will be subject to many challenges, competition and a changing environment. We will try to update our community as things grow and change, but undertake no obligation to do so. Due to the retrospective nature of regulatory action or guidance, we can make no guarantees regarding the legality of the DPH platforms or the DPH token launch in any given jurisdiction. We must operate DPH platforms in accordance with the laws of relevant jurisdictions. As such, the DPH platforms or DPH tokens may not be immediately available in certain countries.
DPH tokens are functional utility smart contracts within the DPH platforms. DPH tokens are non-refundable and are not for speculative investment. No promises of future performance or value are or will be made with respect to DPH tokens, including no promise of inherent value, no promise of continuing payments, and no guarantee that DPH tokens will hold any particular value. DPH tokens are not securities and are not a participation in Digipharm GmbH. DPH tokens hold no rights in Digipharm GmbH. This Whitepaper may be updated or altered, with the latest version of the Whitepaper prevailing over previous versions and we are not obliged to give you any notice of the fact or content of any changes. The latest version of the Whitepaper in English is available at the website [https://digipharm.ch]. While we make every effort to ensure that all data submitted in the Whitepaper is accurate and up to date at the point in time that the relevant version has been disseminated, the proposed Whitepaper is no alternative to consulting an independent 3rd party opinion.
The Whitepaper does not constitute an agreement that binds Digipharm GmbH. Digipharm GmbH, Digipharm GmbH’s directors, officers, employees and associates do not warrant or assume any legal liability arising out of or related to the accuracy, reliability, or completeness of any material contained in the Whitepaper. To the fullest extent permitted by any applicable law in any jurisdiction, Digipharm GmbH disclaim all liability to you and everyone else in respect of the content of this Whitepaper, whether under any theory of tort, contract or otherwise and whether in respect of direct, indirect, consequential, special, punitive or similar damages. Persons who intend to purchase DPH tokens, should seek the advice of independent experts before committing to any action, set out in the Whitepaper.

Post a Comment